RT Journal Article SR Electronic T1 No Evidence for Histamine H4 Receptor in Human Monocytes JF Journal of Pharmacology and Experimental Therapeutics JO J Pharmacol Exp Ther FD American Society for Pharmacology and Experimental Therapeutics SP 519 OP 526 DO 10.1124/jpet.114.218107 VO 351 IS 3 A1 Kristin Werner A1 Detlef Neumann A1 Armin Buschauer A1 Roland Seifert YR 2014 UL http://jpet.aspetjournals.org/content/351/3/519.abstract AB The histamine H4 receptor (H4R) is a classic pertussis toxin-sensitive Gi protein–coupled receptor that mediates increases in intracellular calcium concentration ([Ca2+]i). The presence of H4R in human eosinophils has been rigorously documented by several independent groups. It has also been suggested that H4R is expressed in human monocytes, but this suggestion hinges in part on H4R antibodies with questionable specificity. This situation prompted us to reinvestigate H4R expression in human monocytes. As positive control, we studied human embryonic kidney 293T cells stably expressing the human H4R (hH4R). In these cells, histamine (HA) and the H4R agonist UR-PI376 (2-cyano-1-[4-(1H-imidazol-4-yl)butyl]-3-[(2-phenylthio)ethyl]guanidine) induced pertussis toxin–sensitive [Ca2+]i increases. However, in quantitative real-time polymerase chain reaction studies we failed to detect hH4R mRNA in human monocytes and U937 promonocytes. In human monocytes, ATP and N-formyl-l-methionyl-l-leucyl-l-phenylalanine increased [Ca2+]i, but HA, UR-PI376, and 5-methylhistamine (a dual H4R/H2 receptor agonist) did not. In U937 promonocytes and differentiated U937 cells, HA increased [Ca2+]i, but this increase was mediated via HA H1 receptor. In conclusion, there is no evidence for the presence of H4R in human monocytes.